Biotech firm Mylab developing test to screen multiple Covid variants

Mylab MD Rawal said the firm is making both hardware and software for the test, and it will be ready in the next two months or so

Pune-based biotech firm Mylab Discovery Solutions is working on a new technology platform that would not only detect the presence of coronavirus in a sample, but also be able to screen the variant. The Serum Institute of India (SII)-backed company said that the product would be ready in around two months.

Without divulging details, Hasmukh Rawal, MD of Mylab, told Business Standard the company is working on a molecular diagnostic test that would give results as accurate as of the RT-PCR test. “Unlike the RT-PCR, which takes a few hours to give results, this test platform will be able to give